What Labrador Retriever genetic health issues should I test for before breeding or buying?

Practical guide to Labrador genetic conditions — hip/elbow dysplasia, PRA, EIC, centronuclear myopathy, and the POMC obesity variant. Tests, clearances, and breeding advice.

Overview

This guide summarizes the key genetic health concerns in Labrador Retrievers — what they are, how common they are, what tests are available, and how to interpret results when you’re buying or planning to breed.

Primary sources and recommendations cited include the Orthopedic Foundation for Animals (OFA), American Kennel Club (AKC), Merck Veterinary Manual, and peer-reviewed studies where available.

Major inherited conditions in Labradors

Hip dysplasia

Prevalence and impact: Labradors are a breed at meaningful risk. OFA and breed-health surveys historically report that roughly 10–20% of submitted Labrador hip evaluations show dysplasia of varying severity; exact numbers vary by population and testing bias (owners with problems are more likely to submit films) (OFA). Hip dysplasia is a leading cause of arthritis and decreased quality of life in medium/large dogs (Merck Vet Manual).

Tests and timing:

• OFA (Orthopedic Foundation for Animals) hip evaluation: standard hip radiographs are taken on sedated/anaesthetised dogs and evaluated by board-certified radiologists. OFA gives categorical ratings: Excellent, Good, Fair (these three are generally considered “passing”), Borderline, Mild, Moderate, Severe.
• PennHIP: quantitative distraction index (DI) measuring laxity. DI ranges from 0 (stable) to 1 (very lax). PennHIP can be done earlier than OFA and provides a numeric risk predictor; many breeders aim for DI <0.3.

• For breeding, prefer parents with OFA ratings of Good or Excellent and/or PennHIP DI in the low-risk range. Avoid breeding two dogs with documented dysplasia.
• If using OFA, remember the earliest “official” OFA hip evaluation is at 24 months for a final rating — radiographs taken earlier can be submitted as preliminary but are not final.
• Keep puppies lean and avoid rapid growth and early high-impact exercise — weight and exercise management reduce progression of hip disease (Merck Vet Manual).

Elbow dysplasia

Prevalence: Elbow dysplasia is reported in Labradors with lower prevalence than hips but is still an important cause of forelimb lameness. OFA elbow ratings and breed databases report elbow dysplasia in a small but significant percentage of tested Labs (commonly in the single-digit percentage range depending on the dataset).

Testing and interpretation:

• OFA elbow radiographs: reported as Normal or Dysplastic (grades can be listed). Early signs may be subtle; specialist radiographic views are recommended.

• Include elbow radiographs in pre-breeding screening and consider PennHIP for hips and OFA for elbows together where possible.
• Puppies with elbow disease should have activity and weight carefully managed; surgical options exist for some lesions if symptomatic.

Progressive Retinal Atrophy (PRA) — prcd-PRA

Genetics: prcd-PRA is an autosomal recessive condition: dogs with two copies of the mutant allele (affected/at risk) will develop the disease, carriers (one copy) are clinically normal but can pass the variant on.

Testing: Reliable DNA tests exist for prcd-PRA (commercial labs such as Embark, Paw Print Genetics, UC Davis VGL offer testing).

Actionable advice:

• Before breeding, test both sire and dam. Do not breed two carriers together (carrier × carrier risks 25% affected puppies). Carrier × clear produces no affected pups but 50% carriers — acceptable if managed and documented.
• For buyers: ask for DNA clearances for prcd-PRA or proof of parent clear status.

Exercise-Induced Collapse (EIC)

Genetics and prevalence: EIC is associated with a mutation in the DNM1 gene and behaves as an autosomal recessive trait with incomplete penetrance — many carriers are asymptomatic. Prevalence varies by population; carrier rates in some working lines have been reported as measurable, which makes testing important for breeding (OptiGen/Embark resources).

Testing and interpretation:

• A simple DNA test identifies Clear, Carrier, or Affected status.

• Do not breed two affected dogs. Avoid breeding carrier × carrier to prevent producing affected puppies. Carrier × clear can be acceptable if puppies are tested and buyers informed.
• For affected dogs, avoid strenuous exercise triggers and consult a veterinarian for episode-management plans.

Centronuclear myopathy (CNM)

Genetics: In Labradors, CNM is caused by a specific mutation (tested by commercial labs). It is inherited in an autosomal recessive pattern.

Testing and interpretation:

• DNA tests are available that report Clear, Carrier, or Affected.

• Do not breed two carriers or any affected dogs. Prefer Clear × Clear matings.
• Puppies that are affected typically show signs early; early diagnosis allows supportive care and breeding decisions to prevent recurrence.

The POMC deletion and obesity risk

Prevalence and impact: A notable study (Raffan et al., 2016) found the POMC deletion allele present at substantial frequency in some Labrador populations (reported allele frequencies around the 20% range in the study population), and strongly associated with body weight and food-seeking behavior. The variant increases the risk of obesity — a major health issue that worsens outcomes for joint disease, diabetes risk, and overall longevity.

Testing and interpretation:

• POMC deletion is detected by DNA testing (commercial panels include it). Results indicate whether the dog has 0, 1, or 2 copies of the deletion.

• Treat the POMC variant as a risk factor rather than an absolute disqualifier. Avoid automatic exclusion of carriers from breeding programs, because the allele is common and selection must be balanced against preserving genetic diversity.
• If a dog carries the POMC deletion, plan rigorous weight-control strategies: measured feeding, high-quality diet, scheduled exercise, and regular body condition scoring (aim BCS 4–5/9). Inform puppy buyers about the increased risk and management steps.

Recommended genetic and radiographic testing before breeding

• Hip radiographs evaluated by OFA and/or PennHIP (OFA final rating at >=24 months; PennHIP DI at earlier ages possible).
• Elbow radiographs evaluated by OFA.
• DNA panel including (as a minimum): prcd-PRA, DNM1 (EIC), CNM mutation, POMC deletion (obesity risk). Many breeders also test for degenerative myelopathy (DM) and other breed-relevant variants.
• Eye exam by a board-certified veterinary ophthalmologist, including certification via CERF/Canine Eye Registration Foundation or equivalent (some countries use ECVO) for inherited eye disease.

• OFA (orthopedic evaluations) and PennHIP (hip laxity quantification)
• UC Davis Veterinary Genetics Lab (VGL), Embark, Paw Print Genetics, Wisdom Panel, OptiGen — these labs offer breed-specific panels and single-gene tests.
• CHIC (Canine Health Information Center) documentation: meeting CHIC requirements for Labradors typically involves hips, elbows, eye exams and DNA testing — check the OFA/CHIC pages for current requirements.

How to interpret health clearances

• OFA hips: “Excellent/Good/Fair” = acceptable; “Borderline/Mild/Moderate/Severe” = varying degrees of dysplasia — avoid breeding dogs with Mild or worse unless paired with a completely clear mate and only with a plan to improve the offspring and monitor carefully. The safest breeding strategy is to use dogs rated Good/Excellent.
• PennHIP DI: lower is better; breeders commonly select parents whose DI falls into the lower 25–50% percentile for the breed. Use breed-specific percentiles published by PennHIP to interpret risk.

• Clear (or homozygous normal): no copies of the tested mutant allele — cannot produce affected pups for that variant.
• Carrier (heterozygous): one copy — clinically normal for recessive conditions, but 50% of offspring may inherit the allele if bred to a Clear, and 25% affected if bred to another Carrier.
• Affected (homozygous mutant): has two copies — will develop disease (for recessive conditions) or be at high risk — should not be bred for that mutation.

• For autosomal recessive serious diseases (PRA, CNM, EIC): do not breed two carriers or any pair that could produce affected offspring (i.e., avoid carrier × carrier and affected × any).
• For risk alleles like POMC: manage via selection and lifestyle interventions. Avoid consigning valuable genetic lines to oblivion — balanced breeding and counseling is preferred.
• Document and disclose: breeders should provide copies of clearances and DNA results to buyers and other breeders. Transparency protects the breed and informs good decisions.

Practical advice for owners and breeders

• Ask for documented OFA/PennHIP and DNA results when buying a puppy; reputable breeders will share health clearances and CHIC numbers.
• Test early: DNA tests can be performed on cheek swabs at any age; hip/elbow radiographs have age minimums (hips often at 24 months for OFA final rating; PennHIP can be earlier).
• Keep puppies lean and feed measured diets; monitor body condition frequently — obesity worsens joint disease.
• If you plan to breed, discuss results with a veterinary geneticist or your club’s health committee — decisions about carriers are context-dependent.
• Use available resources: OFA, PennHIP, AKC Canine Health Foundation, Merck Veterinary Manual, peer-reviewed literature, and accredited genetic testing labs.

Key Takeaways

• Labradors carry a set of well-characterized inherited risks: hip and elbow dysplasia, prcd‑PRA, EIC, centronuclear myopathy, and a common POMC deletion that increases obesity risk.
• Radiographs (OFA and/or PennHIP) and DNA panels are complementary: radiographs assess joint conformation; DNA tests identify specific inherited variants.
• Interpret clearances carefully: OFA ratings (Excellent/Good/Fair) and PennHIP DI low percentiles are preferred; DNA results of Clear/Carrier/Affected determine safe breeding combinations.
• Practical breeding: avoid producing affected puppies (don’t mate two carriers for recessive conditions); manage POMC-positive dogs via nutrition and activity rather than automatic exclusion.
• Transparency and documentation (OFA, CHIC, DNA reports) are essential when buying or breeding Labradors.

• Provide a checklist of exact tests and minimum ages to request from a breeder or require before mating, or
• Generate a sample “health-clearance disclosure form” a breeder could give buyers.

References and resources

• Orthopedic Foundation for Animals (OFA): https://www.ofa.org
• American Kennel Club (AKC) Canine Health Resources: https://www.akc.org
• Merck Veterinary Manual — orthopedic topics: https://www.merckvetmanual.com
• Raffan E, Dennis R, et al., “A deletion in the canine POMC gene is associated with weight and appetite in obesity-prone Labrador retriever dogs” (study describing POMC deletion; see PubMed/Journal listings)
• PennHIP program information: https://www.pennhip.org
• Canine Health Information Center (CHIC): https://www.ofa.org/chic
• Commercial genetic testing labs: Embark, Paw Print Genetics, UC Davis VGL, Wisdom Panel, OptiGen

Frequently Asked Questions